Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX
- PMID: 17367605
- DOI: 10.1016/j.humpath.2006.07.020
Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX
Abstract
Carbonic anhydrase IX (CAIX) is a transmembrane enzyme involved in the reversible metabolism of carbon dioxide to carbonic acid and, hence, in physiological pH regulation. It also participates in cellular differentiation and proliferation, its expression being absent in most normal tissues. It has been recently postulated that the hypoxia-inducible factor (HIF-1) pathway up-regulated by hypoxia accounts for CAIX overexpression in most human tumors. In the present study, we examined the expression of this enzyme in diffuse gliomas of astrocytic origin in relation to vascular endothelial growth factor (VEGF) and HIF-1alpha expression, proliferation rate (as assessed with Ki-67 antigen), microvessel morphology, and survival. Of 84 cases analyzed, 61 cases (72.6%) displayed strong membrane and/or cytoplasmic expression of CAIX and were grouped as positive. Immunoreactivity tended to have a perinecrotic distribution and increased in parallel with the extent of necrosis (P < .001) and histologic grade (P < .001). A positive correlation was also noted with HIF-1alpha and VEGF expression (P < .001), proliferation rate (P = .010), microvessel density (P = .004), and microvessel caliber parameters (P = .014-.038). In univariate survival analysis, increased CAIX expression was associated with shortened survival in the entire cohort (P < .0001), along with VEGF (P = .0205) and HIF-1alpha levels (P = .0190). Multivariate analysis selected the interaction model of CAIX, with grade and age as the only parameters independently affecting survival. CAIX expression was also the only significant parameter for the survival of patients with grades II/III. We conclude that CAIX may be used as a prognostic indicator in diffuse astrocytomas to refine the information provided by grade. Given the role of CAIX in the acidification of tumor environment and its up-regulation by hypoxia, it is thought that CAIX expression may be linked to resistance of tumor cells to radiotherapy by allowing them to acclimatize to a hypoxic and acidic microenvironment.
Similar articles
-
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.Clin Cancer Res. 2002 Aug;8(8):2595-604. Clin Cancer Res. 2002. PMID: 12171890
-
Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1481-7. doi: 10.1016/j.ijrobp.2006.07.1376. Epub 2006 Oct 23. Int J Radiat Oncol Biol Phys. 2006. PMID: 17056190
-
Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.Neuropathol Appl Neurobiol. 2004 Jun;30(3):267-78. doi: 10.1111/j.1365-2990.2003.00535.x. Neuropathol Appl Neurobiol. 2004. PMID: 15175080
-
Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.Subcell Biochem. 2014;75:221-54. doi: 10.1007/978-94-007-7359-2_12. Subcell Biochem. 2014. PMID: 24146382 Free PMC article. Review.
-
The role of carbonic anhydrase IX in hypoxia control in OSCC.J Oral Pathol Med. 2013 Jan;42(1):1-8. doi: 10.1111/j.1600-0714.2012.01144.x. Epub 2012 Mar 14. J Oral Pathol Med. 2013. PMID: 22417164 Review.
Cited by
-
Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis.Front Oncol. 2016 Mar 29;6:69. doi: 10.3389/fonc.2016.00069. eCollection 2016. Front Oncol. 2016. PMID: 27066453 Free PMC article. Review.
-
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma.Neurology. 2009 Oct 13;73(15):1200-6. doi: 10.1212/WNL.0b013e3181bc0184. Neurology. 2009. PMID: 19822869 Free PMC article.
-
The Acidic Brain-Glycolytic Switch in the Microenvironment of Malignant Glioma.Int J Mol Sci. 2021 May 24;22(11):5518. doi: 10.3390/ijms22115518. Int J Mol Sci. 2021. PMID: 34073734 Free PMC article. Review.
-
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept.Clin Cancer Res. 2011 Jul 15;17(14):4872-81. doi: 10.1158/1078-0432.CCR-11-0271. Epub 2011 Jun 1. Clin Cancer Res. 2011. PMID: 21632852 Free PMC article. Clinical Trial.
-
"Paradoxical" findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab.Oncotarget. 2017 Oct 24;8(61):103890-103899. doi: 10.18632/oncotarget.21978. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262608 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources